Document is current
Any future updates will be listed below
-
Authors
Marcelin, Clément https://orcid.org/0000-0002-2328-0952
Linet, Thomas
Jambon, Eva
Maaloum, Rim
Le Bras, Yann
Pinsolle, Vincent
Labreze, Christine
Cornelis, François H.
- License Information
-
More Information
Article History
Received: 14 October 2024
Revised: 3 February 2025
Accepted: 23 February 2025
First Online: 5 April 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Francois H. Cornelis.
: The authors of this manuscript declare relationships with the following companies: Francois H. Cornelis is a consultant for GE HealthCare, Varian and IceCure. The author Francois H. Cornelis discloses that MSK (Memorial Sloan Kettering Cancer Center) is funded through the NIH/NCI Cancer Center Support Grant P30 CA008748. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise. No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Ethical approval for this study was obtained from Comité d’Éthique de la Recherche Centre Hospitalier Universitaire de Bordeaux, under approval number CER-BDX 2023-100.
: This manuscript shares partial data with our previous publications: Cornelis et al [] and Cornelis et al [], focusing on efficacy and safety. However, the current study provides novel insights into prognostic factors of clinical efficacy that have not been previously reported.
:
